000			02160nas a22003135i 4500
001			1179-187X
003			DE-He213
005			20260610082520.0
007			cr nn 008mamaa
008			150723s||||||||sz uu poo|||||| b|EN |d
022			_a1179-187X
024	7		_a10.1007/40256.1179-187X _2doi
210	1	0	_aAm J Cardiovasc Drugs
245	1	0	_aAmerican Journal of Cardiovascular Drugs _h[electronic resource] / _cedited by Amitabh Prakash.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Adis.
300			_bonline resource.
520			_aThe American Journal of Cardiovascular Drugs promotes rational therapy and effective patient management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures. The journal includes: Short overviews of contentious or emerging issues (Current Opinions and Leading Articles, respectively). Comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease. Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Therapy in practice reviews covering optimum management of specific conditions. Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine. Original research articles reporting the results of well-designed clinical studies, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies.
650		0	_aCardiology.
650		0	_aTherapeutics.
650		0	_aPharmacology.
650	1	4	_aCardiology.
650	2	4	_aTherapeutics.
650	2	4	_aPharmacology.
700	1		_aPrakash, Amitabh. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x1175-3277
856	4	0	_uhttps://doi.org/10.1007/40256.1179-187X _zHybrid
999			_c3533 _d3533